TY - JOUR
T1 - Post-COVID-19 sequelae are associated with sustained SARS-CoV-2-specific CD4+ immune responses
AU - Venegoni, Chiara
AU - RAINERI, DAVIDE
AU - Mazzucca, Camilla Barbero
AU - Ghazanfar, Ali
AU - CAPPELLANO, GIUSEPPE
AU - Baricich, Alessio
AU - Patrucco, Filippo
AU - ZEPPEGNO, Patrizia
AU - Gramaglia, Carla Maria
AU - Balbo, Piero Emilio
AU - CANTALUPPI, Vincenzo
AU - Patti, Giuseppe Rocco Salvatore
AU - GIORDANO, Mara
AU - MANFREDI, MARCELLO
AU - ROLLA, Roberta
AU - SAINAGHI, Pier Paolo
AU - PIRISI, Mario
AU - BELLAN, Mattia
AU - CHIOCCHETTI, Annalisa
PY - 2025
Y1 - 2025
N2 - Background
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to widespread post-acute sequelae of COVID-19 (PASC), affecting multiple body systems. Despite its prevalence, PASC’s pathogenesis remains unclear, with hypotheses suggesting viral persistence, immune activation, and autoimmune responses among the pathogenetic mechanism. This study aimed to evaluate T cell memory response in PASC patients, one year post-hospital discharge and correlate it with clinical parameters to identify a potential PASC-associated fingerprint.
Methods
Peripheral blood mononuclear cells (PBMCs) from PASC patients and healthy controls (HC) were stimulated with a pool of spike peptides. CD4+ and CD8+ T cell responses were evaluated by flow cytometry using the activation-induced markers assay (AIM).
Results
Findings showed significant activation of the CD4+ T cell compartment, with a higher proportion of responders among PASC patients. Central memory (CM) T cells expressing pro-inflammatory cytokines were more prevalent in responders. Clinical correlations revealed higher SARS-CoV-2-specific T cell responses in patients with reduced diffuse lung capacity for carbon monoxide (DLCO) and residual symptoms.
Conclusion
These immune changes, especially in CM T cells, could play a pivotal role in PASC’s development and persistence, impacting patients’ daily lives.
AB - Background
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to widespread post-acute sequelae of COVID-19 (PASC), affecting multiple body systems. Despite its prevalence, PASC’s pathogenesis remains unclear, with hypotheses suggesting viral persistence, immune activation, and autoimmune responses among the pathogenetic mechanism. This study aimed to evaluate T cell memory response in PASC patients, one year post-hospital discharge and correlate it with clinical parameters to identify a potential PASC-associated fingerprint.
Methods
Peripheral blood mononuclear cells (PBMCs) from PASC patients and healthy controls (HC) were stimulated with a pool of spike peptides. CD4+ and CD8+ T cell responses were evaluated by flow cytometry using the activation-induced markers assay (AIM).
Results
Findings showed significant activation of the CD4+ T cell compartment, with a higher proportion of responders among PASC patients. Central memory (CM) T cells expressing pro-inflammatory cytokines were more prevalent in responders. Clinical correlations revealed higher SARS-CoV-2-specific T cell responses in patients with reduced diffuse lung capacity for carbon monoxide (DLCO) and residual symptoms.
Conclusion
These immune changes, especially in CM T cells, could play a pivotal role in PASC’s development and persistence, impacting patients’ daily lives.
UR - https://iris.uniupo.it/handle/11579/203522
U2 - 10.1016/j.intimp.2025.114103
DO - 10.1016/j.intimp.2025.114103
M3 - Article
SN - 1567-5769
VL - 148
JO - International Immunopharmacology
JF - International Immunopharmacology
ER -